Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut ...Middle East

New York Post - Technology
Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut
Shares of Atai Life Sciences, backed by billionaire investor Peter Thiel, surged 40 percent in their U.S. stock market debut on Friday, giving the German psychedelics startup a market capitalization of $3.19 billion. The Berlin-based biotech startup, which is exploring the use of psychedelic treatments for mental illnesses, raised $225 million from selling 15 million shares in...

Hence then, the article about thiel backed psychedelic drugmaker valued at 3 2b in nasdaq debut was published today ( ) and is available on New York Post ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut )

Apple Storegoogle play

Last updated :

Also on site :



Latest News